Speeding pharma ’s slow sustainability journey

As world leaders gather in Glasgow for COP26 to discuss the next steps in the bid to tackle climate change, pharma ’s sustainability record is coming under greater scrutiny than ever.The public glare reveals much room for improvement but also, happily, many positive next steps industry leaders can take for the good of their own companies as well as of society at large, and of the planet.This is the message that Gary Cohen, President, Health Care Without Harm wants them to take away as the imperative to do more and with greater urgency becomes clearer.There are several pillars around which pharma can effect positive change, says Cohen. These include:Carbon tracking and transparency Among the most obvious measures that pharma is now being obliged to take is joining with other industry sectors to committing to setting ambitious and credible carbon cutting targets and implementing plans to make this happen.  Healthcare contributes 4.4% of total global emissions and pharmaceuticals make up a significant part of this.The world ’s healthcare systems, led by the likes of the UK’s NHS and Kaiser Permanente, are waking up to the urgency of the task of broader sustainability and are moving up a gear from merely setting internal climate targets, to striving to  achieve further and faster change.Given that a significant source of the emissions of every business is from outside them along their supply chains, tracking these is becoming an unavoidable part of the process. “They ne...
Source: EyeForPharma - Category: Pharmaceuticals Authors: Source Type: news